Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

PFA's dominance & other key EP trends | FDA approves next-gen mitral valve | Virtual nursing helps practices combat burnout

News You Need to Know Today
PFA's dominance & other key EP trends | FDA approves next-gen mitral valve | Virtual nursing helps practices combat burnout
Thursday, April 30, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

PFA's dominance and other key electrophysiology trends on display at Heart Rhythm 2026

Heart Rhythm 2026 Program Chair DJ Lakkireddy, MD, spoke to Cardiovascular Business during the conference about several key EP trends. 

READ MORE >
Heart Rhythm 2026 Program Chair Dhanunjaya "DJ" Lakkireddy, MD, MBA, FHRS, Executive Medical Director, Kansas City Heart Rhythm Institute, and professor of medicine at the University of Kansas Health System, offers an overview of key trends in electrophysiology (EP) technology.
Share on Twitter Share on Facebook Share on Linkedin

PFA's dominance and other key electrophysiology trends on display at Heart Rhythm 2026

Share on Twitter Share on Facebook Share on Linkedin
Heart Rhythm 2026 Program Chair Dhanunjaya "DJ" Lakkireddy, MD, MBA, FHRS, Executive Medical Director, Kansas City Heart Rhythm Institute, and professor of medicine at the University of Kansas Health System, offers an overview of key trends in electrophysiology (EP) technology.
Heart Rhythm 2026 Program Chair DJ Lakkireddy, MD, spoke to Cardiovascular Business during the conference about several key EP trends. 
READ MORE >

FDA approves next-gen mitral valve from Medtronic

The Mosaic Neo mitral bioprosthesis can be implanted through sternotomy, minimally invasive cardiac surgery or robotic access. 

READ MORE >
Mosaic Neo mitral valve from Medtronic
Share on Twitter Share on Facebook Share on Linkedin

FDA approves next-gen mitral valve from Medtronic

Share on Twitter Share on Facebook Share on Linkedin
Mosaic Neo mitral valve from Medtronic
The Mosaic Neo mitral bioprosthesis can be implanted through sternotomy, minimally invasive cardiac surgery or robotic access. 
READ MORE >

Virtual nursing staff may help save cardiology departments from burnout

The idea is spreading thanks to a new startup focused on providing support for cardiologists.

READ MORE >
doctorwithpatient.jpg
Share on Twitter Share on Facebook Share on Linkedin

Virtual nursing staff may help save cardiology departments from burnout

Share on Twitter Share on Facebook Share on Linkedin
doctorwithpatient.jpg
The idea is spreading thanks to a new startup focused on providing support for cardiologists.
READ MORE >

Featured Articles

FDA warns public about vascular device after 3 deaths

The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.

READ MORE >
Physician warning
Share on Twitter Share on Facebook Share on Linkedin

FDA warns public about vascular device after 3 deaths

Share on Twitter Share on Facebook Share on Linkedin
Physician warning
The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.
READ MORE >

IV fluids recalled over possible contamination—patients face risk of vascular complications

Particulate matter may be present in certain 1-liter containers of B. Braun Medical's Lactated Ringer's Injections. If this enters a patient's circulatory system, it could lead to a series of adverse events.

READ MORE >
B. Braun Medical’s Lactated Ringer’s Injections
Share on Twitter Share on Facebook Share on Linkedin

IV fluids recalled over possible contamination—patients face risk of vascular complications

Share on Twitter Share on Facebook Share on Linkedin
B. Braun Medical’s Lactated Ringer’s Injections
Particulate matter may be present in certain 1-liter containers of B. Braun Medical's Lactated Ringer's Injections. If this enters a patient's circulatory system, it could lead to a series of adverse events.
READ MORE >

Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform

Ultreon 3.0 was built to capture and evaluate OCT images, providing real-time guidance during complex PCI procedures.

READ MORE >
Ultreon 3.0 Abbott
Share on Twitter Share on Facebook Share on Linkedin

Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform

Share on Twitter Share on Facebook Share on Linkedin
Ultreon 3.0 Abbott
Ultreon 3.0 was built to capture and evaluate OCT images, providing real-time guidance during complex PCI procedures.
READ MORE >

How to implement AI-powered coronary plaque analysis software—and ensure you get paid

The use of AI to evaluate plaque buildup in CCTA images has been one of cardiology’s biggest ongoing trends. Implementing this software into existing workflows, however, can be a challenge. An upcoming webinar is focused on providing guidance to hospitals and cardiology practices hoping to learn more about this topic. 

READ MORE >
cvi42 | Plaque Circle Cardiovascular Imaging
Share on Twitter Share on Facebook Share on Linkedin

How to implement AI-powered coronary plaque analysis software—and ensure you get paid

Share on Twitter Share on Facebook Share on Linkedin
cvi42 | Plaque Circle Cardiovascular Imaging
The use of AI to evaluate plaque buildup in CCTA images has been one of cardiology’s biggest ongoing trends. Implementing this software into existing workflows, however, can be a challenge. An upcoming webinar is focused on providing guidance to hospitals and cardiology practices hoping to learn more about this topic. 
READ MORE >

In Case You Missed It

Medline recalls millions of devices due to safety risk—FDA threatens ‘regulatory action’ in warning letter

Millions of angiographic syringes were recalled due to a risk of parts becoming loose or disconnected. The FDA, unhappy with Medline's response to this situation, sent the company a new warning letter. 

READ MORE >
warning safety alert recall healthcare issue
Share on Twitter Share on Facebook Share on Linkedin

Medline recalls millions of devices due to safety risk—FDA threatens ‘regulatory action’ in warning letter

Share on Twitter Share on Facebook Share on Linkedin
warning safety alert recall healthcare issue
Millions of angiographic syringes were recalled due to a risk of parts becoming loose or disconnected. The FDA, unhappy with Medline's response to this situation, sent the company a new warning letter. 
READ MORE >

New gene therapy may help protect the hearts of patients with Friedreich's ataxia

A majority of deaths from Friedreich's ataxia are associated with heart complications. A new treatment years in the making could provide some much-needed relief.

READ MORE >
Video interview with Ronald Crystal, MD, chair, Department of Genetic Medicine at Weill Cornell Medicine, presented late-breaking findings on a first in-human, virus-delivered gene therapy trial to stop cardiomyopathy death in patients with Friedreich Ataxia (FA). #ACC #ACC26
Share on Twitter Share on Facebook Share on Linkedin

New gene therapy may help protect the hearts of patients with Friedreich's ataxia

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Ronald Crystal, MD, chair, Department of Genetic Medicine at Weill Cornell Medicine, presented late-breaking findings on a first in-human, virus-delivered gene therapy trial to stop cardiomyopathy death in patients with Friedreich Ataxia (FA). #ACC #ACC26
A majority of deaths from Friedreich's ataxia are associated with heart complications. A new treatment years in the making could provide some much-needed relief.
READ MORE >

Deepak Bhatt discusses some of the most impactful trials at ACC 2026

Bhatt describes a mix of drug, device and strategy trials pointing to advances in cardiovascular science.
 

READ MORE >
To unpack the large number of lat-breaking trials at the American College of Cardiology 2026 meeting, Cardiovascular Business spoke in the above video interview with Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, director of the Mount Sinai Fuster Heart Hospital, who highlighted several studies he felt had the most scientific impact. This included a mix of drug, device and strategy trials pointing to advances in cardiology. #ACC #ACC26
Share on Twitter Share on Facebook Share on Linkedin

Deepak Bhatt discusses some of the most impactful trials at ACC 2026

Share on Twitter Share on Facebook Share on Linkedin
To unpack the large number of lat-breaking trials at the American College of Cardiology 2026 meeting, Cardiovascular Business spoke in the above video interview with Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, director of the Mount Sinai Fuster Heart Hospital, who highlighted several studies he felt had the most scientific impact. This included a mix of drug, device and strategy trials pointing to advances in cardiology. #ACC #ACC26
Bhatt describes a mix of drug, device and strategy trials pointing to advances in cardiovascular science. 
READ MORE >

In Other News

Nonprofit physician support program faces lawsuit from two docs who say it irreparably damaged their careers

Washington Physicians Health Program (WPHP), a contractor with the state health department, is accused of trapping two physicians into mental health treatment as a condition of maintaining their medical residency jobs. Plaintiffs in the lawsuit are seeking class action status. 

READ MORE >
The Anesthesia Patient Safety Foundation (APSF), a related organization of the American Society of Anesthesiologists (ASA), this week released a statement on the criminalization of medical errors. The APSF said criminal prosecution is unjust and counterproductive is healthcare organizations want to find ways to mitigate errors by understanding how they happen and create protocols or IT systems can can help prevent future errors. The criminal trial of nurse RaDonda Vaught was counterproductive to safety.
Share on Twitter Share on Facebook Share on Linkedin

Nonprofit physician support program faces lawsuit from two docs who say it irreparably damaged their careers

Share on Twitter Share on Facebook Share on Linkedin
The Anesthesia Patient Safety Foundation (APSF), a related organization of the American Society of Anesthesiologists (ASA), this week released a statement on the criminalization of medical errors. The APSF said criminal prosecution is unjust and counterproductive is healthcare organizations want to find ways to mitigate errors by understanding how they happen and create protocols or IT systems can can help prevent future errors. The criminal trial of nurse RaDonda Vaught was counterproductive to safety.
Washington Physicians Health Program (WPHP), a contractor with the state health department, is accused of trapping two physicians into mental health treatment as a condition of maintaining their medical residency jobs. Plaintiffs in the lawsuit are seeking class action status. 
READ MORE >

Radiology AI vendor Azra acquires rival firm focused on incidental findings

The Nashville, Tennessee, company—which offers AI to monitor radiology reports for unexpected findings—has reached a deal to buy Thynk Health for an undisclosed sum. 

READ MORE >
Healthcare M&A, mergers and acquisitions business deal.
Share on Twitter Share on Facebook Share on Linkedin

Radiology AI vendor Azra acquires rival firm focused on incidental findings

Share on Twitter Share on Facebook Share on Linkedin
Healthcare M&A, mergers and acquisitions business deal.
The Nashville, Tennessee, company—which offers AI to monitor radiology reports for unexpected findings—has reached a deal to buy Thynk Health for an undisclosed sum. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Private equity unlikely to dominate cardiology | Cardiology opposes Medicare AI prior authorization | New AATS leaders
The real impact of RVU cuts in electrophysiology | TAVR changes on the way | Cardiology groups celebrate bill | BP drug recalled
Blood may leak out of Impella introducers | Leadless conduction and Bachmann's pacing | US study for microvascular disease
Top 10 most popular cardiology video interviews this past month
Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI
CCTA scan provides a wake-up call | Resistance training & heart attack risk in women | New ultrasound tech | AFib & grout
FDA clears first surgical valve of its kind | Family files $17M lawsuit | BATMAN to the rescue | Major trends at SCCT 2026

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup